Mantle cell lymphoma

The goal of this study was to analyze the presenting features, natural history, and prognostic factors in 59 patients with well characterized mantle cell lymphoma (MCL).

[1]  W. Benedict,et al.  Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Weisenburger,et al.  Mantle cell lymphoma-- an entity comes of age. , 1996, Blood.

[3]  E. Campo,et al.  Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. , 1996, American journal of clinical pathology.

[4]  F. Bosch,et al.  Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. , 1996, The American journal of pathology.

[5]  F. Bosch,et al.  p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. , 1996, Blood.

[6]  E. Noordijk,et al.  Mantle-cell lymphoma: a population-based clinical study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. López-Guillermo,et al.  CNS involvement in mantle-cell lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Hagenbeek,et al.  Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D C Louie,et al.  p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). , 1995, Blood.

[10]  T. Lister,et al.  Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Garcia-conde,et al.  Mantle cell lymphoma: a new lymphoproliferative entity with definite histopathological patterns, clinical characteristics and prognostic factors, and an investigational therapeutic approach. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  D. Weisenburger,et al.  The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  F. Cavalli,et al.  Patterns of survival in mantle cell lymphoma. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  B. Nathwani,et al.  A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. , 1995, Blood.

[15]  S. Pittaluga,et al.  Mantle cell lymphoma: a clinicopathological study of 55 cases , 1995, Histopathology.

[16]  A. López-Guillermo,et al.  PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .

[17]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[18]  B. Coiffier,et al.  European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL) , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  G. Salles,et al.  Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. , 1994, Blood.

[20]  F. Cavalli,et al.  Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. , 1994, Leukemia & lymphoma.

[21]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[22]  F. Berger,et al.  Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. , 1993, Blood.

[23]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[24]  S. Swerdlow,et al.  Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. , 1992, Cancer research.

[25]  C. Mecucci,et al.  Chromosome 11q rearrangements in B non Hodgkin's lymphoma , 1992, British journal of haematology.

[26]  N. Harris,et al.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[28]  E. Jaffe,et al.  Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic and Immunophenotypic Spectrum and Clinical Correlations , 1990, The American journal of surgical pathology.

[29]  M. Engelhard,et al.  Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis , 1989, Hematological oncology.

[30]  D. Weisenburger,et al.  Mantle‐zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma , 1982, Cancer.

[31]  C. Berard,et al.  Histopathology of malignant lymphomas , 1974 .

[32]  M. Pike,et al.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. , 1973, Biometrics.

[33]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[34]  E. Campo,et al.  Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.

[35]  D. Weisenburger,et al.  Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. , 1987, Blood.